TIBSOVO: payments to doctors
Payments that named TIBSOVO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $4.1M
- Providers
- 6,063
- Transactions
- 15,961
- Average per transaction
- $255
The per-transaction average — $255 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,063 providers the average total is $673, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Servier Pharmaceuticals LLC | $2,206,793 | 54.1% |
| Agios Pharmaceuticals, Inc. | $1,745,090 | 42.8% |
| Servier Affaires Medicales | $80,167 | 2.0% |
| LES Laboratoires Servier | $31,087 | 0.8% |
| Servier Bioinnovation | $14,745 | 0.4% |